Cargando…
Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry
Sclerostin is the protein product of the SOST gene and is known for its inhibitory effects on bone formation. The monoclonal antibody against sclerostin has been approved as a novel treatment method for osteoporosis. Oral health is one of the essential aspects of general human health. Hereditary bon...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102262/ https://www.ncbi.nlm.nih.gov/pubmed/35562828 http://dx.doi.org/10.1186/s12967-022-03417-4 |